Zhonghong Pulin Medical Products Co. Ltd. Total Assets
Zhonghong Pulin Medical Products Co. Ltd. total assets. Based on the latest financial reports, Zhonghong Pulin Medical Products Co. Ltd. (300981) holds total assets worth CN¥7.69 Billion CNY (≈ $1.13 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 300981 market cap for the company's overall valuation and market capitalisation.
Total Assets of Zhonghong Pulin Medical Products Co. Ltd. (2013–2025)
Total assets of Zhonghong Pulin Medical Products Co. Ltd. from 2013 to 2025. This chart illustrates how Zhonghong Pulin Medical Products Co. Ltd.'s total assets have evolved over time, based on quarterly financial data. See Zhonghong Pulin Medical Products Co. Ltd share price for real-time trading data and today's change.
Zhonghong Pulin Medical Products Co. Ltd. - Asset Composition Analysis
Zhonghong Pulin Medical Products Co. Ltd. Total Assets Breakdown (December 2025)
Zhonghong Pulin Medical Products Co. Ltd. total assets breakdown as of December 2025. Zhonghong Pulin Medical Products Co. Ltd.'s total assets of CN¥7.69 Billion consist of 63.6% current assets and 36.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 16.2% |
| Accounts Receivable | CN¥401.59 Million | 5.4% |
| Inventory | CN¥623.59 Million | 8.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥142.48 Million | 1.9% |
| Goodwill | CN¥90.92 Million | 1.2% |
Asset Composition Trend (2013–2025)
This chart illustrates how Zhonghong Pulin Medical Products Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Zhonghong Pulin Medical Products Co. Ltd's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhonghong Pulin Medical Products Co. Ltd.'s current assets represent 63.6% of total assets in 2025, an increase from 57.5% in 2013.
- Cash Position: Cash and equivalents constituted 16.2% of total assets in 2025, up from 5.6% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 3.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 8.4% of total assets.
Zhonghong Pulin Medical Products Co. Ltd. Competitors by Total Assets
Key competitors of Zhonghong Pulin Medical Products Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Autek China Inc
SHE:300595
|
China | CN¥6.40 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Crossject
PA:ALCJ
|
France | €30.43 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.39 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Zhonghong Pulin Medical Products Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.53 | 2.99 | 10.04 |
| Quick Ratio | 2.20 | 2.62 | 9.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.14 Billion | CN¥3.33 Billion | CN¥4.82 Billion |
Zhonghong Pulin Medical Products Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Zhonghong Pulin Medical Products Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.23 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | 2.9% |
| Total Assets | CN¥7.44 Billion |
| Market Capitalization | $948.25 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhonghong Pulin Medical Products Co. Ltd.'s assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhonghong Pulin Medical Products Co. Ltd.'s assets grew by 2.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhonghong Pulin Medical Products Co. Ltd. (2013–2025)
The table below shows the annual total assets of Zhonghong Pulin Medical Products Co. Ltd. from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥7.44 Billion ≈ $1.09 Billion |
+2.87% |
| 2024-12-31 | CN¥7.23 Billion ≈ $1.06 Billion |
+2.46% |
| 2023-12-31 | CN¥7.06 Billion ≈ $1.03 Billion |
+3.53% |
| 2022-12-31 | CN¥6.82 Billion ≈ $997.49 Million |
-4.69% |
| 2021-12-31 | CN¥7.15 Billion ≈ $1.05 Billion |
+94.73% |
| 2020-12-31 | CN¥3.67 Billion ≈ $537.43 Million |
+241.35% |
| 2019-12-31 | CN¥1.08 Billion ≈ $157.44 Million |
+10.36% |
| 2018-12-31 | CN¥974.94 Million ≈ $142.66 Million |
+39.74% |
| 2017-12-31 | CN¥697.69 Million ≈ $102.09 Million |
+10.94% |
| 2016-12-31 | CN¥628.88 Million ≈ $92.03 Million |
+9.26% |
| 2015-12-31 | CN¥575.60 Million ≈ $84.23 Million |
+17.74% |
| 2014-12-31 | CN¥488.86 Million ≈ $71.54 Million |
-1.22% |
| 2013-12-31 | CN¥494.91 Million ≈ $72.42 Million |
-- |
About Zhonghong Pulin Medical Products Co. Ltd.
Zhonghong Pulin Medical Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable health protection products, sterile medical devices, and life support solutions in China and internationally. It operates through the Health Protection Products Division; Safe Infusion Products Division; and Innovation and Incubation Product Division… Read more